Innovation

A viral gene inducing toxicity in insect cells: increased efficacy through protein engineering

Texas Tech University System Office of Technology Commercialization
posted on 07/15/2011

Invention Description:

This technology provides an improved means to control insects, involving a biological control method to induce toxicity in targeted insects using iridoptin.  It can be used to induce high levels of apoptosis and inhibition of host pertain synthesis in insect cells.  It is the first viral toxin against non-lepidopteran insects and is distinct from existing bacterial toxins, such as Bacillus thuringiensis toxins, which are not effective against most beetles, including the boll weevil, and the Baculoviridae, which is the main group of viruses currently used as biological control agents. 

Market Applications:

Iridoptin will have use in the control of agricultural pests.  It will increase productivity and reduce disease transfer by vectors and household pests.  It may have applications in cancer therapy and other medical applications where apoptosis is critical to removal of certain cells.

Features, Benefits, & Advantages:

  • Improved biological control methods remove the adverse side effects presented from chemical control to beneficial insects and groundwater.

  • The use of iridoptin is more efficient in inducing apoptosis and inhibiting host protein synthesis than earlier discovered viral proteins.

  • The economic impact of boll weevils, aphids, silver leaf whiteflies, and noctuids is estimated at $3.7 billion annually for the U.S. alone.

Intellectual Property:

U.S. Patent application 12/205.857 filed on 09/06/2008.  Applications also filed for Brazil and China.  

Development Stage:

This technology is part of an active and ongoing research project. It is available for licensing.

 

]]>


Innovation Details
 

File Number: D-0550 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact David McClure at Texas Tech University System Office of Technology Commercialization for more information.

Request more info via email request more info
People

Principal Investigator:

Shan Bilimoria Shan Bilimoria

Innovations (1)


Case Manager:

David McClure David McClure

Innovations (18)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Martin Lehr, Osage University Partners

"iBridge is a great resource for entrepreneurs who are looking for technologies to license. Many premiere universities including Michigan, Columbia, MIT, Penn, and Harvard, participate in the iBridge program."  read more...